8-K current report · filed Jul 29, 2026

Pulmonx Corp (LUNG) 8-K Current Report: July 29, 2026

Item 2.02Item EX-99.1LUNG overview

Short answer

Pulmonx Corp (LUNG) filed an 8-K current report with the SEC on July 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Pulmonx announced financial results for Q2 fiscal 2026 ended June 30, 2026.

Pulmonx Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Pulmonx announced financial results for Q2 fiscal 2026 ended June 30, 2026
  • Full revenue, profitability, cash flow and guidance details appear in Exhibit 99.1, the attached earnings release

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $22.8M, down 5% YoY, with U.S. revenue $14.2M down 4%
  • International revenue $8.6M, down 6%, primarily from absent China sales pending registration renewal
  • International revenue excluding China grew 12% YoY, indicating underlying overseas commercial momentum
  • Record gross margin 78% versus 72%, while operating expenses fell 16% to $26.8M
  • Net loss narrowed to $10.1M and adjusted EBITDA loss to $5.1M, but cash fell to $55.8M as of June 30, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Pulmonx Corp 8-K filings

Get the next LUNG 8-K as it lands

Follow LUNG for push alerts, or ask the research agent what this filing means.